241 related articles for article (PubMed ID: 4009952)
1. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Nishimura T; Tabuki K; Takashima T; Takagi M
Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
[TBL] [Abstract][Full Text] [Related]
2. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
[TBL] [Abstract][Full Text] [Related]
3. [Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Haruta T; Kuroki S; Okura K; Kobayashi Y
Jpn J Antibiot; 1985 Feb; 38(2):359-72. PubMed ID: 3847523
[TBL] [Abstract][Full Text] [Related]
4. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Toyonaga Y; Kurosu Y; Sugita M; Nakamura H; Takahashi T; Hori M
Jpn J Antibiot; 1985 Feb; 38(2):373-413. PubMed ID: 3847524
[TBL] [Abstract][Full Text] [Related]
5. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M
Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
[TBL] [Abstract][Full Text] [Related]
6. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
Nagamatsu I; Horiguchi S; Hatae T
Jpn J Antibiot; 1985 Feb; 38(2):287-95. PubMed ID: 3847518
[TBL] [Abstract][Full Text] [Related]
8. [Laboratory and clinical studies on BRL 25000 (clavulanic acid -amoxicillin) granules in the pediatric field].
Cho K; Sakata H; Fujita K; Yoshioka H; Mukai N
Jpn J Antibiot; 1985 Feb; 38(2):253-62. PubMed ID: 4009947
[TBL] [Abstract][Full Text] [Related]
9. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Nakazawa S; Sato H; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Chikaoka H; Tazoe K; Nakada Y; Niino K
Jpn J Antibiot; 1985 Feb; 38(2):296-308. PubMed ID: 3847519
[TBL] [Abstract][Full Text] [Related]
10. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Miyachi Y; Ueda S; Hayakawa F; Nakashima T; Hakamada S; Kuno K
Jpn J Antibiot; 1985 Feb; 38(2):423-30. PubMed ID: 4009951
[TBL] [Abstract][Full Text] [Related]
11. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Sunakawa K; Ishizuka Y
Jpn J Antibiot; 1985 Feb; 38(2):319-26. PubMed ID: 3892075
[TBL] [Abstract][Full Text] [Related]
12. [Clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules on skin and soft tissue infections in the field of pediatrics].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
Jpn J Antibiot; 1985 Feb; 38(2):507-37. PubMed ID: 3892077
[TBL] [Abstract][Full Text] [Related]
13. [Experimental and clinical evaluation of the BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Shinozaki T; Meguro H; Fujii R; Mashiko Z; Okamoto Y; Arimasu O
Jpn J Antibiot; 1985 Feb; 38(2):269-86. PubMed ID: 4009949
[TBL] [Abstract][Full Text] [Related]
14. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
Jpn J Antibiot; 1985 Feb; 38(2):309-18. PubMed ID: 3847520
[TBL] [Abstract][Full Text] [Related]
15. [Experimental and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
Minamitani M; Hachimori K; Kaneda K
Jpn J Antibiot; 1985 Feb; 38(2):415-22. PubMed ID: 4009950
[TBL] [Abstract][Full Text] [Related]
16. [Clinical experience with BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
Nagata K; Yokoyama M
Jpn J Antibiot; 1985 Feb; 38(2):263-8. PubMed ID: 4009948
[TBL] [Abstract][Full Text] [Related]
17. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of otorhinolaryngology].
Kawamura S; Sugita R; Fujimaki Y; Deguchi K
Jpn J Antibiot; 1983 Mar; 36(3):500-8. PubMed ID: 6553606
[TBL] [Abstract][Full Text] [Related]
18. [In vitro susceptibilities of BRL 25000 (clavulanic acid-amoxicillin) against causative organisms in the field of obstetrics and gynecology].
Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Yoshihara H; Oda S; Matsumoto Y; Ikegami R; Sato K
Jpn J Antibiot; 1986 Mar; 39(3):842-52. PubMed ID: 3488425
[TBL] [Abstract][Full Text] [Related]
19. [In vitro susceptibilities of causative organisms isolated from patients with primary respiratory tract infections to BRL 25000 (clavulanic acid/amoxicillin)].
Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Sato K; Fukumoto T
Jpn J Antibiot; 1985 Oct; 38(10):2797-808. PubMed ID: 3878415
[TBL] [Abstract][Full Text] [Related]
20. [Effect of BRL 25000 (clavulanic acid-amoxicillin) on bacterial flora in human feces].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K
Jpn J Antibiot; 1985 Feb; 38(2):441-80. PubMed ID: 3847525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
